- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Caprelsa (vandetanib)
Total 106 results
-
Genzyme, a Sanofi CompanyActive, not recruitingThyroid CancerUnited States, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark, France, Germany, Hungary, India, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Romania, Russian Federation, Serbia, Spain, Sweden, Switz...
-
National Cancer Institute (NCI)CompletedMultiple Endocrine Neoplasia Type 2A | Multiple Endocrine Neoplasia Type 2B | Medullary Thyroid CarcinomaUnited States
-
Samsung Medical CenterAstraZenecaCompleted
-
National Cancer Institute (NCI)CompletedRenal Cancer | Von Hippel LindauUnited States
-
PrECOG, LLC.AstraZenecaCompletedLung Cancer | Non Small Cell Lung CancerUnited States
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerUnited States, France
-
Genzyme, a Sanofi CompanyTerminated
-
University of LiverpoolAstraZenecaUnknownPancreatic CancerUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedMetastatic Medullary Thyroid CancerBelgium
-
Genzyme, a Sanofi CompanyCompletedEvaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer (VERIFY)Differentiated Thyroid CancerUnited States, Sweden, Brazil, Italy, Poland, Spain, China, Russian Federation, France, Japan, Denmark, Czechia
-
Genzyme, a Sanofi CompanyCompleted
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedCarcinoma, Hepatocellular | Metastatic Colorectal CancerUnited Kingdom
-
M.D. Anderson Cancer CenterUnited States Department of Defense; AstraZenecaCompleted
-
Genzyme, a Sanofi CompanyWorldwide Clinical TrialsCompletedSymptomatic, Aggressive, Sporadic, Unresectable, Locally | Advanced/Metastatic Medullary Thyroid Cancer (MTC)Belgium, Italy, Netherlands, Spain, France, Germany, United Kingdom, Luxembourg
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerItaly, Spain, Romania, Netherlands, Canada, United States, Switzerland, Australia
-
National Cancer Institute (NCI)CompletedGlioblastoma Multiforme | Gliosarcoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Anaplastic Mixed OligoastrocytomaUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedMetastatic Sporadic Medullary Thyroid CancerItaly
-
National Cancer Institute (NCI)TerminatedRenal Cell Carcinoma | Renal Cell Cancer | Hereditary LeiomyomatosisUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
St. Jude Children's Research HospitalCompletedBrain and Central Nervous System TumorsUnited States
-
Genzyme, a Sanofi CompanyCompletedThyroid NeoplasmsSweden, France, Spain, Norway, Belgium, Denmark, Switzerland
-
Velindre NHS TrustAstraZeneca; Cancer Research UKUnknownNeoplasmsUnited Kingdom
-
Genzyme, a Sanofi CompanyActive, not recruitingTo Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid CancerThyroid CancerUnited States, Italy, Poland, Russian Federation, United Kingdom, Netherlands, Israel, Czechia, India
-
Genzyme, a Sanofi CompanyCompletedUnresectable Locally Advanced or Metastatic, Medullary Thyroid CarcinomaJapan
-
Genzyme, a Sanofi CompanyActive, not recruitingMedullary Thyroid Cancer | Locally Advanced or Metastatic Medullary Thyroid CancerAustralia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Denmark, Finland, Germany, Greece, India, Israel, Italy, Korea, Republic of, Poland, Russian Federation, Sweden, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, HepatocellularTaiwan
-
Genzyme, a Sanofi CompanyCompleted
-
M.D. Anderson Cancer CenterAstraZenecaTerminatedNon-Small Cell Lung CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; AstraZeneca; Brigham and Women's HospitalCompleted
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedCarcinoma | Lung Cancer | Non-Small Cell Lung
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingMedullary Thyroid CancerUnited States, Canada, Spain, China, Australia, Japan, India, Germany, France, Netherlands, Czechia, Brazil, Korea, Republic of, Italy, Israel, Greece, United Kingdom, Belgium, Poland, Russian Federation
-
National Cancer Institute (NCI)Completed
-
University of Colorado, DenverAstraZenecaCompleted
-
National Cancer Institute (NCI)TerminatedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States
-
National Cancer Institute (NCI)Terminated
-
Genzyme, a Sanofi CompanyCompletedBiliary Tract Cancer | Gallbladder Cancer | Ampullary Carcinoma | Cancer Of The Extrahepatic Bile DuctItaly
-
Ronald WeigelAstraZenecaTerminatedInvasive Breast CancerUnited States
-
Cancer Research UKAstraZenecaCompletedCancer | Non Small Cell Lung CancerUnited Kingdom
-
SanofiGenzyme, a Sanofi CompanyCompletedProstate Cancer | Metastatic | Hormone RefractoryBrazil, South Africa, Sweden, Germany, Hungary
-
Leonard ApplemanAstraZenecaCompletedAdvanced Incurable Solid MalignancyUnited States
-
National Cancer Institute (NCI)Terminated
-
Genzyme, a Sanofi CompanyTerminatedOvarian CancerGermany
-
SanofiCompleted
-
SanofiCompletedMedullary Thyroid CancerUnited States
-
SanofiTerminatedNon-small Cell Lung Cancer (NSCLC)Netherlands
-
SanofiCompleted
-
SanofiCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant NeoplasmUnited States